Try it
Biochemistry · Clinical biochemistry: bone turnover markers
Sample itemA postmenopausal woman is monitored on a bisphosphonate. Which of the following is a marker of bone resorption rather than bone formation?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Serum C-terminal telopeptide of type I collagen (CTX)
CTX is released when osteoclasts degrade type I collagen, so it measures resorption and falls rapidly with antiresorptive therapy. P1NP, osteocalcin and bone-specific ALP are products of osteoblasts and indicate bone formation. Urinary deoxypyridinoline is another resorption marker.
Option by option
A. Bone-specific alkaline phosphatase
Bone-specific alkaline phosphatase is an osteoblast enzyme and reflects formation.
B. Serum C-terminal telopeptide of type I collagen (CTX) (correct)
Correct. CTX is a collagen breakdown product released during osteoclastic resorption.
C. Procollagen type I N-terminal propeptide (P1NP)
P1NP is the propeptide released during type I collagen synthesis, so it marks formation.
D. Serum osteocalcin
Osteocalcin is made by osteoblasts and is a formation marker.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Biochemistry questions
- Nucleotide metabolismA 4-year-old boy has intellectual disability, dystonia, self-mutilation and hyperuricaem…
- VitaminsA patient with megaloblastic anaemia and mild neurological signs has raised serum methyl…
- Amino acid metabolismA baby has a mousy odour, fair skin and developmental delay. Which enzyme is deficient?
- Glycogen storage diseasesA child has severe fasting hypoglycaemia, hepatomegaly, lactic acidosis and hyperuricaem…